Centralized Pregnancy Registries May Benefit Small Firms Most - FDA
Executive Summary
A centralized pregnancy registry may be most beneficial for smaller pharmaceutical and biotech companies by addressing resource and infrastructure limitations, FDA suggested at a March 29 meeting of the Pregnancy Labeling Subcommittee.